ARCHIVES

Includes June issue of Business & Regulatory Report.

This article is from The Cancer Letter archive.

Vol. 28 No. 26 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

New DRCCA Board Skeptical Of CIs renewal, Proposal For Cytopathology

September 26, 1980

Help Wanted: Varmus Irked by Having to Fill Jobs With Salaries NCI Can’t Afford to Pay

July 6, 2012

Vitamin D Not Associated With Risk For Less Common Cancers, Study Finds

July 30, 2010

Second-Generation CML Drugs Show Promise For Frontline

December 26, 2008

The Clinical Trials Working Group: NCI panel considers plan to centralize clinical trial review and prioritization. NCI director faults system for duplication, “equivocal results.”

August 13, 2004

In Brief: Lippman Leads M.D. Anderson Clinical Prevention; Baylin Named Ludwig Professor

May 10, 1996